Romergoline

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameRomergoline
Drug Alias NameFCE-23884
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonistsDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsPsychotic DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corporation
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A